Clinical Trials Logo

Filter by:
NCT ID: NCT05156307 Recruiting - Colorectal Cancer Clinical Trials

Accuracy and Predictive Values for Colorectal Cancer of Quantitative FIT in Symptomatic Patients in Primary Care

Start date: May 20, 2021
Phase:
Study type: Observational

The aim of this study is to determine accuracy and predictive values for colorectal cancer of a faecal quantitative immunochemical test (FIT) in unselected symptomatic patients presenting in primary care. Main reference test will be linkage to a nationwide colorectal cancer registry.

NCT ID: NCT05156281 Recruiting - Clinical trials for Relapsing Multiple Sclerosis

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

REMODEL-2
Start date: December 13, 2021
Phase: Phase 3
Study type: Interventional

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)

NCT ID: NCT05155878 Recruiting - Surgery Clinical Trials

Prognostic Factors in Periampullary Tumors and Cysts

Start date: September 1, 2021
Phase:
Study type: Observational [Patient Registry]

The project aims at analysing prognostic and predictive factors involved in diagnostics and surgical treatment of cysts and tumors in the pancreas and periampullary region using both clinical data and blood and tissue samples for biomarker development and validation.

NCT ID: NCT05155774 Completed - Treatment Adherence Clinical Trials

Treatment Adherence With Twin-Blocks for Correction of Class II Malocclusion

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

To compare the effect of two control intervals (once every 4th week or once every 6th week) on the wear time of a Twin Block removable appliance.

NCT ID: NCT05154461 Completed - Clinical trials for Healthy Adult Volunteers

Intestinal Ketone Bodies Interfere With the Glycemic Control

Start date: December 5, 2021
Phase: N/A
Study type: Interventional

The ketone body (KB) ß-hydroxybutyrate will be given to eight fasting healthy volunteers of both sexes in order to observe the effects after an oral glucose tolerance test (OGTT) over 2 h. Then, a standard lunch will be served at 12.00, as well as an afternoon snack at 15.00. Each participant will be its own control and participates in a randomised two-way cross over design; the KB are released in the stomach-duodenum, or in the ileum-colon. Peripheral blood samples are taken for endpoint GLP-1 analyses.

NCT ID: NCT05153785 Recruiting - Postoperative Pain Clinical Trials

Perioperative Intravenous Lidocaine in Liver Surgery

Start date: November 15, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

This is a randomized double blinded placebo-controlled study, conducted in Lund, Sweden. Patients will be randomized in two groups, with a ratio of 1:1. The experimental arm will receive intravenous Lidocaine perioperatively, and the Control arm will receive placebo, i.e. normal Saline. Postoperative both arms will get routine pain Control with PCA, Patient Controlled Analgesia with an intravenous Oxycodone-infusion. Outcome-measures will include patients pain intensity scoring, and opioid consumption.

NCT ID: NCT05152979 Recruiting - Stroke Clinical Trials

Effects of Verb Network Strengthening Treatment (VNeST) on Word Finding in Aphasia

Start date: January 16, 2022
Phase: N/A
Study type: Interventional

Although there is evidence that speech-language therapy may improve speech in language disorders following left hemisphere stroke there is still a lack of evidence for which types of therapy are effective. Furthermore, in Sweden, as well as in several other countries, access to speech-language therapy is limited. The purpose of this clinical trial is to compare outcome from Verb Network Strengthening Treatment (VNeST) provided as In-Clinic therapy (I-CT) or as synchronous telepractice therapy (TP-T).

NCT ID: NCT05152524 Recruiting - Ischemic Stroke Clinical Trials

Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever

DISTALS
Start date: March 25, 2022
Phase: N/A
Study type: Interventional

The objective of the DISTALS Study is to evaluate the safety and effectiveness of the Tigertriever 13 Revascularization Device in restoring blood flow in the neurovasculature by removing thrombus in patients presenting within 24 hours of onset with an ischemic stroke with disabling neurological deficits due to a primary distal vessel occlusion (DVO), as compared to medical management.

NCT ID: NCT05152264 Recruiting - Clinical trials for Endometriosis-related Pain

Transcutaneous Electrical Nerve Stimulation for Endometriosis-related Chronic Pain

Start date: November 12, 2021
Phase: N/A
Study type: Interventional

The study evaluates the effect of TENS (transcutaneous electrical nerve stimulation) as add-on treatment compared with conventional analgesic treatment in patients with endometriosis-related chronic pain. Patients with frequent pain and high pain intensity will be randomized to additional treatment with TENS or conventional treatment for 8 weeks to evaluate the acute effects of TENS treatment (n=40). Patients with endometriosis-related pain that is not frequent or without high pain intensity constitute an external control group. All patients in the study will receive TENS treatment for a total of 16 weeks, for evaluation of long-term effects of TENS treatment.

NCT ID: NCT05151913 Completed - Clinical trials for Intrahepatic Cholestasis of Pregnancy

The Microbiome Composition in Women With Recurring Intrahepatic Cholestasis of Pregnancy (ICP)

Start date: February 14, 2017
Phase:
Study type: Observational

This is an exploratory non-therapeutic study to study the microbiome patterns during pregnancy in women with ICP in order to identify specific bacterial strains for further product development.